RCS - IP Group PLC - Investor presentation on life sciences

IPAnnouncement

02/11/2022 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221102:nRSB1211Fa&default-theme=true

RNS Number : 1211F  IP Group PLC  02 November 2022

 FOR RELEASE ON  2 November 2022

 

IP Group plc - Investor presentation on Life Sciences

 

IP Group plc (LSE: IPO) ("IP Group" or "the Company"), which develops
world-changing science and technology businesses across life sciences,
technology and cleantech, is pleased to announce that it will host an investor
presentation titled 'Life Sciences: Changing Medicine'on Wednesday 30 November
2022.

 

The event, which will be led by Dr Sam Williams, Managing Partner of Life
Sciences, will be hybrid (both in person and virtual) and take place from 9am
- 11am. For further information and to register to attend, please visit the
events section of our website: https://www.ipgroupplc.com/events
(https://www.ipgroupplc.com/events) .

 

The online update will be hosted through the Investor Meet Company platform.
Questions can be submitted in advance of the event via the Investor Meet
Company Platform up to 9am the day before the meeting or at any time during
the live presentation. Investors can sign up to Investor Meet Company for free
via: https://www.investormeetcompany.com/ip-group-plc/register-investor
(https://www.investormeetcompany.com/ip-group-plc/register-investor) .
Investors who already follow IP Group plc on the Investor Meet Company
platform will automatically be invited.

 

No material new information will be released by the Company during the
presentation.

 

For more information, please contact:

 

 IP Group plc                                             www.ipgroupplc.com (http://www.ipgroupplc.com)
 Liz Vaughan-Adams, Communications                        +44 (0) 20 7444 0050

+44 (0) 20 7444 0062/+44 (0) 7967 312125
 Charlotte Street Partners
 David Gaffney                                            +44 (0) 7854 609998
 Andrew Wilson                                            +44 (0) 7810 636995

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across life
sciences, technology and cleantech. The Group has a strong track record of
success, having been the founder investor in a number of high-profile
companies including Oxford Nanopore Technologies plc, and has one of the most
exciting portfolios of high-growth businesses in Europe. The Group also owns
Parkwalk, the UK's largest growth EIS fund manager which backs world-changing
technologies emerging from the UK's leading universities and research
institutions. IP Group is listed on the Main Market of the London Stock
Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABTBATMTIMBLT